Senior Scientist
Coriolis Pharma Research GmbH
Martinsried, Bayern, Germany
Dr. Brecht Vanbillemont, a senior scientist at Coriolis Pharma in Munich, Germany, specialized in lyophilization process and formulation development. Dr. Vanbillemont is a licensed pharmacist and qualified person. He has directed numerous CRO development studies across various modalities. Dr. Vanbillemont oversees the different aspects of drug product development, from formulation screening to process optimization and late-phase robustness studies. He holds a doctoral degree from Ghent University, where his research focused on continuous freeze-drying of parenterals and orally disintegrating tablets under the guidance of Prof. Thomas De Beer. He has authored 18 scientific publications and presented at numerous international conferences. Dr. Vanbillemont was a visiting scholar for 6 months at the University of Colorado, mentored by Prof. John Carpenter, further enriching his expertise in the field.
Disclosure information not submitted.
Developing Robust Lyophilization Processes for Biopharmaceuticals through Process Understanding
Monday, October 21, 2024
9:30 AM – 10:00 AM MT